Afuco™ Anti-Human LTA ADCC Therapeutic Antibody, ADCC Enhanced
Anti-LTA ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibodies, including specified portions or variants, specific for at least one human lymphotoxin alpha (LTα) protein, have been implicated in inflammatory diseases, autoimmune diseases, viral, bacterial and parasitic infections, malignancies, and/or neurogenerative diseases.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-482CL |
| Pricing | Inquiry |
| Host | Human |
| Target | LTA |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | ≥1 year at -20°C. If the reconstituted antibody cannot be used within two weeks, it should be aliquoted into smaller vials and stored at -20°C |